About Jrf Research Private Limited
Data last updated: 08 January 2026
Jrf Research Private Limited is a private limited company based in Vapi, Gujarat, India. It specialises in consumer and professional services, a part of the broader travel and hospitality sector. Incorporated on 07 December 2012, the company has been in operation for over 14 years.
Registered with ROC Ahmedabad under CIN U73100GJ2012PTC072922.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandra Rajnikant Shroff and Jaidev Rajnikant Shroff.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: C/O. United Phosphorus Limited 3 – 11 G I D C Vapi, Gujarat, India – 396195.
The company is associated with 1 brand - Jrf Global.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jrfglobal.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressC/O. United Phosphorus Limited 3 – 11 G I D C Vapi, Gujarat, India – 396195
-
IndustryTravel and Hospitality, Consumer Professional Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Jrf Research Private Limited
Jrf Research Private Limited operates one associated brand: JRF Global. These brands represent Jrf Research Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Delivers comprehensive preclinical services for the healthcare industry. | jrfglobal.com |
Competitors & Alternatives of Jrf Research Private Limited
Brands and companies operating in the same space as Jrf Research Private Limited include PHAXIAM, Gubra, BioQual and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
PHAXIAM
|
Antibacterial treatments using bacteriophages are developed for resistant infections. | Lyon, France, France | 2004 |
Gubra
|
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | Horsholm, Denmark, Denmark | 2008 |
BioQual
|
Contract research on infectious disease models is conducted. | Rockville, United States, United States | 1981 |
Tigermed
|
Drug development and preclinical services are provided by Tigermed. | Hangzhou, China, China | 2004 |
Gentronix
|
In-vitro and in-vivo genetic toxicology screening services are provided. | Alderley Edge, United Kingdom, United Kingdom | 1999 |
Aquila BioMedical
|
Preclinical services in immunology, regeneration, neuroscience, and histology are provided. | Edinburgh, United Kingdom, United Kingdom | 2011 |
ReveraGen
|
Steroids for Duchenne muscular dystrophy treatment are developed. | Rockville, United States, United States | 2008 |
VGXI
|
Contract developer and manufacturer of plasmids | The Woodlands, United States, United States | 1997 |
Shanghai Semero Biotechnology
|
Diversified preclinical services for brain-related disorders are provided. | Shanghai, China, China | 2014 |
Auditor Details of Jrf Research Private Limited
Jrf Research Private Limited is audited by PRADIP R. SHAH & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRADIP R. SHAH & CO. | blur-value | blur-value | blur-value |
Board of Directors of Jrf Research Private Limited
Jrf Research Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sandra Rajnikant Shroff
Also directs:
Nivi Trading Limited, Sanguine Novaseeds Private Limited, Shroff Envirotral Private Limited and 5 more
|
Director | 07 Dec 2012 | 13 Years 7 Months | Current |
|
Jaidev Rajnikant Shroff
Also directs:
Nivi Trading Limited, Shroff Envirotral Private Limited, Demuric Holdings Pvt Ltd(Tr Co From Maharashtra) and 5 more
|
Director | 07 Dec 2012 | 13 Years 7 Months | Current |
| Vikram Rajnikant Shroff | Director | 07 Dec 2012 | 13 Years 7 Months | Current |
|
Rajnikant Devidas Shroff
Also directs:
Ultima Newpro Llp, Nivi Trading Limited, Sanguine Novaseeds Private Limited and 5 more
|
Director | 07 Dec 2012 | 13 Years 7 Months | Current |
Financials of Jrf Research Private Limited FY 2025 filings available
Jrf Research Private Limited reported revenue of ₹- (up ) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Jrf Research Private Limited
As of FY 2023, Jrf Research Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Jrf Research Private Limited
Jrf Research Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Jrf Research Private Limited
View historical data on people associated with Jrf Research Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Jrf Research Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Jrf Research Private Limited
GSTIN & GST Filing Data of Jrf Research Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Jrf Research Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Jrf Research Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Jrf Research Private Limited
MSME Payment Delays by Jrf Research Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Jrf Research Private Limited
Subsidiaries & Group Companies of Jrf Research Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Jrf Research Private Limited with ownership details.
MCA Filings & Documents of Jrf Research Private Limited
MCA Filings & Documents of Jrf Research Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Jrf Research Private Limited
Frequently Asked Questions about Jrf Research Private Limited
Jrf Research Private Limited is an active private limited company in the travel and hospitality sector based in Vapi, Gujarat, India. It was incorporated on 07 December 2012 (14+ years old) and is registered under CIN U73100GJ2012PTC072922.
The current directors of Jrf Research Private Limited are:
The primary industry of Jrf Research Private Limited is travel and hospitality. The company specifically operates in consumer professional services. The company is currently active in this sector.
Jrf Research Private Limited can be reached at the registered office: CO. United Phosphorus Limited 3 – 11 G I D C Vapi, Gujarat, India – 396195, or through the website jrfglobal.com.
The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.
The company has its registered office at CO. United Phosphorus Limited 3 – 11 G I D C Vapi, Gujarat, India – 396195.